C-MAC Video Stylet vs. Video Endoscope

December 6, 2022 updated by: University Hospital Inselspital, Berne

Is a Rigid Fiberscope With a Flexible Tip Superior to Standard Flexible Fiberoptic Intubation: a Prospective Multicentre Randomised Controlled Trial

The purpose of the study is to compare first attempt success rates and time until intubation to establish the learning curves of the participating anaesthesiologists with two different intubation strategies: (Karl Storz C-MAC VS (Video Stylet) and the standard flexible intubation video endoscope at the study site.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The intubation of the trachea is a crucial procedure in anaesthesia and emergency medicine, therefore it is considered as one of the core competences in these disciplines. Novices in the field need to learn intubation fast and without harming patients to ensure a patent airway if needed.

According to the European Union of Medical Specialists (U.E.M.S., 1050 Brussels, BE), every anaesthesiologist has to master different techniques for the airway management. One is the fiberoptic intubation in awake or asleep patients, to manage a difficult airway. For further training, these core competences need to be extended during the career, from level A (has knowledge) to level D (teaches or supervises others). As the intubation with flexible fiberoptic scopes is the gold standard for the management of a known difficult airway, the investigators want to compare this to a new technique. The use of flexible scopes do not guarantee easy intubation in every difficult airway situation and intubation sometimes is difficult to achieve and requires high proficiency (unability to steer, unability to overcome an anatomical obstacle). Various approaches were introduced by the medical device industry to overcome that problem. One new device is a rigid video stylet with a flexible tip (Karl Storz C-MAC VS), which is an advancement of the older rigid scope "Bonfils" (Karl Storz).

Intubation training with the Bonfils stylet has been shown to require about 20 consecutive tracheal intubations by novices to reach expert time. Learning curves for fiberoptic intubations seem to be similar, but a greater variance was observed. A study of the investigators research-group (unpublished data, KEK 247/09), comparing learning curves between the rigid fiberoptic Bonfils and the semi-rigid fiberoptic SensaScope suggested a 90% success rate for intubation within 60 seconds after about 15 trials (Bonfils) and 20 trials (SensaScope). In comparison, there is no validated data for the use of rigid scopes with flexible tips, as these tool are very new.

Video stylets are tools originally designed for difficult airway management as well. The C-MAC VS combines rigid and semi-rigid abilities. Intubation seems to become very easy. But yet, there is no data available which proves that assumption. Thus the study wants to evaluate if intubation success and time is superior with the C-MAC Video Scope compared to the difficult intubation gold standard, the intubation with a standard flexible fiberoptic scope.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ontario
      • London, Ontario, Canada
        • Not yet recruiting
        • LHSC / St. Joesephs
        • Contact:
          • Rüdiger Noppens, MD, PHD
      • Zaragoza, Spain
        • Not yet recruiting
        • Miguel Servet University Hospital
        • Contact:
          • Guillermo I. Perez Navarro, MD, PHD
      • Bern, Switzerland, 3010
        • Recruiting
        • Inselspital, Bern University Hospital
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Anaesthesiologists starting in the respective anaesthesia department who are not experienced with tracheal intubation with the study devices
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Novice to the C-MAC VS
  • No/few fiberoptic oral asleep intubation experience (max. 5x during the last year)

Exclusion Criteria:

  • More than 5 uses during the past year of either one of the study devices
  • Not available at the study site during entire study (expected drop outs)
  • Not able to fill out English case reports
  • Patients: Planned delayed extubation (e.g. planned transfer to ICU)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: C- MAC VS
Intubation with C- MAC VS
The C-MAC VS is a new device on the airway management aid market. It will be used according to the instructions of the distributor. Before the study starts on humans, each study participants will do at least 5 intubations on an airway manikin or more until he or she feels confident to use the device.
Active Comparator: Video Endoscope
Intubation with standard fiberoptic scope
Fiberoptic video endoscopic devices are standard aids to facilitate intubation on all study sites and are used according to the instructions to use. To facilitate fiberoptic intubation a macintosh blade to raise the root of tongue will be used. Also with these devices the study participants need at least 5 trials to intubate a manikin (or more to feel confident) before they are going to use the study device in patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time (seconds) to successful orotracheal intubation during the first successful attempt.
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (a trial consists of a maximum of 2 intubation attempts, each with a maximum duration of 120 seconds)
With the C-MAC VS and the standard flexible scope
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (a trial consists of a maximum of 2 intubation attempts, each with a maximum duration of 120 seconds)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall time from startpoint to glottic view
Time Frame: It cannot be longer than 240 seconds and is defined for unsuccessful trials, i.e. if no intubation was established, as 360 seconds.
The overall time is defined as the total time to glottic view, summarized over all attempts.
It cannot be longer than 240 seconds and is defined for unsuccessful trials, i.e. if no intubation was established, as 360 seconds.
Time to first end expiratory CO2 reading
Time Frame: Start: Device passes patients lips; End: First end expiratory CO2 reading (trial in total not >240 seconds)
After the airway is secured the first end expiratory CO2 is shown.The investigators will use the standard non-invasive monitoring of the University Hospital to measure the end expiratory CO2
Start: Device passes patients lips; End: First end expiratory CO2 reading (trial in total not >240 seconds)
Number of intubation attempts
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
End of an attempt defined as: device has to be completely removed out of the patient's airway.
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
Subjective difficulty of the intubation procedure
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds
The VAS- Visual analogue scale (score 1-10) is used. It is a measurement instrument for subjective characteristics that cannot be directly measured. Therefore numbers are used to evaluate.
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds
Cormack/Lehane grade
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
The Cormack/Lehane grade is used to describe the laryngeal view during laryngoscopy. It is rated by the supervisor.
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
Limited or restricted vision through the devices (either C MAC VS or a standard flexible scope)
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
The view can be clear or blurred.
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
Correlation to patients' anatomical characteristics
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
To assess the influence of difficulty with the airway
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
Patients vital parameter such as heart rate, during the intubation attempt
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
The investigators will use the standard non-invasive monitoring of the University Hospital to measure the heart rate.
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
Patients vital parameter such as blood pressure, during the intubation attempt
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
The investigators will use the standard non-invasive monitoring of the University Hospital to measure the blood pressure (in millimeters of mercury)
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
Patients vital parameter such as oxygen saturation, during the intubation attempt
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
The investigators will use the standard non-invasive monitoring of the University Hospital to measure the oxygen saturation (SpO2 in percent).
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
Participants characteristics and demographic data
Time Frame: Before the study session starts (up to 24 hours before the first intubation attempt)
Basic demographic data (including years of experience in anaesthesia).
Before the study session starts (up to 24 hours before the first intubation attempt)
Patients demographic data such as height
Time Frame: During the process of screening, up to 24 hours before the study session starts
The size of each patient will be presented in meter/centimeter
During the process of screening, up to 24 hours before the study session starts
Patients demographic data such as weight
Time Frame: During the process of screening, up to 24 hours before the study session starts
The weight of each patient will be presented in kilograms
During the process of screening, up to 24 hours before the study session starts
Patients demographic data such as ASA risc classification (ASA= American Society of Anaesthesiologists)
Time Frame: During the process of screening, up to 24 hours before the study session starts
The ASA grading system is used to evaluate the degree of a patient's physical state before selecting the anesthetic or before performing surgery.
During the process of screening, up to 24 hours before the study session starts
Patients demographic data such as age
Time Frame: During the process of screening, up to 24 hours before the study session starts
The age of each patient will be presented in years.
During the process of screening, up to 24 hours before the study session starts
Patients demographic data such as gender
Time Frame: During the process of screening, up to 24 hours before the study session starts
The gender of each patient will be presented in female or male.
During the process of screening, up to 24 hours before the study session starts

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of injuries due to intubation attempts
Time Frame: Follow-Up on the first post anaesthesia day (maximum 24 hours post anaesthesia)
Dental damage, mucosal damage, hoarseness, sore throat, swallowing disorders
Follow-Up on the first post anaesthesia day (maximum 24 hours post anaesthesia)
How often a "hand over to specialist" happens
Time Frame: Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)
The device has to be handed over to the supervisor
Start: Device passes patients lips; End: Device is completely removed out of the tracheal tube (trial in total not >240 seconds)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lorenz Theiler, Prof., M.D, Department of Anaesthesiology and Pain Therapy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2018

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

November 8, 2018

First Submitted That Met QC Criteria

November 20, 2018

First Posted (Actual)

November 21, 2018

Study Record Updates

Last Update Posted (Estimate)

December 7, 2022

Last Update Submitted That Met QC Criteria

December 6, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2018-00629

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intubation

Clinical Trials on C- MAC VS

3
Subscribe